• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于大规模抗体生产的基于膜的连续捕获色谱平台的技术经济分析。

Techno-economic analysis of membrane-based continuous capture chromatography platforms for large-scale antibody production.

作者信息

Romero Juan J, Jenkins Eleanor W, Birtwistle Marc R, Husson Scott M

机构信息

Department of Chemical and Biomolecular Engineering, Clemson University, Clemson, South Carolina, USA.

School of Mathematical and Statistical Sciences, Clemson University, Clemson, South Carolina, USA.

出版信息

Biotechnol Prog. 2025 Apr 24:e70033. doi: 10.1002/btpr.70033.

DOI:10.1002/btpr.70033
PMID:40270480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12353975/
Abstract

Continuous manufacturing platforms and membrane chromatography are process technologies with the potential to reduce production costs and minimize process variability in monoclonal antibody production. This study presents a simulation and optimization framework to perform techno-economic analyses of these strategies. Multi-objective optimization was used to compare batch and continuous multicolumn operating modes and membrane and resin process alternatives, revealing performance differences in productivity and cost of goods attributed to variations in dynamic binding capacity, media geometry, and process residence time. From the set of optimal process configurations, we selected one membrane and one resin platform alternative yielding the highest net present values to undergo sensitivity analyses involving variations in batch cadence and product selling price. For the scenarios considered in this work, membrane continuous platforms showed benefits in the cost of goods and process mass intensity. Their shorter residence time compared to resins positions them as a viable alternative for single-use capture chromatography. Moreover, this low residence time makes membrane platforms more flexible to changes in throughput, an essential feature for integrating capture into fully continuous processes.

摘要

连续制造平台和膜色谱是具有降低单克隆抗体制造成本和最小化工艺变异性潜力的工艺技术。本研究提出了一个模拟和优化框架,以对这些策略进行技术经济分析。多目标优化用于比较分批和连续多柱操作模式以及膜和树脂工艺替代方案,揭示了由于动态结合容量、介质几何形状和工艺停留时间的变化而导致的生产率和商品成本的性能差异。从一组最优工艺配置中,我们选择了一个膜平台和一个树脂平台替代方案,它们具有最高的净现值,以进行涉及分批节奏和产品售价变化的敏感性分析。对于本工作中考虑的场景,膜连续平台在商品成本和工艺质量强度方面显示出优势。与树脂相比,它们较短的停留时间使其成为一次性捕获色谱的可行替代方案。此外,这种低停留时间使膜平台对产量变化更具灵活性,这是将捕获集成到完全连续工艺中的一个基本特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/bc684769fcc1/BTPR-41-e70033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/5a9362d24a41/BTPR-41-e70033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/71979a8c4a34/BTPR-41-e70033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/38ed69641e09/BTPR-41-e70033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/b5a982107218/BTPR-41-e70033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/bc684769fcc1/BTPR-41-e70033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/5a9362d24a41/BTPR-41-e70033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/71979a8c4a34/BTPR-41-e70033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/38ed69641e09/BTPR-41-e70033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/b5a982107218/BTPR-41-e70033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f090/12531935/bc684769fcc1/BTPR-41-e70033-g001.jpg

相似文献

1
Techno-economic analysis of membrane-based continuous capture chromatography platforms for large-scale antibody production.用于大规模抗体生产的基于膜的连续捕获色谱平台的技术经济分析。
Biotechnol Prog. 2025 Apr 24:e70033. doi: 10.1002/btpr.70033.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Digital interventions in mental health: evidence syntheses and economic modelling.数字干预在精神健康中的应用:证据综合和经济建模。
Health Technol Assess. 2022 Jan;26(1):1-182. doi: 10.3310/RCTI6942.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Techno-Economic Analysis of Membrane-Based Purification Platforms for AAV Vector Production.用于腺相关病毒载体生产的基于膜的纯化平台的技术经济分析
Biotechnol Bioeng. 2025 Sep;122(9):2400-2409. doi: 10.1002/bit.29034. Epub 2025 May 29.
6
Short-Term Memory Impairment短期记忆障碍
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.

本文引用的文献

1
Comparative Evaluation of Commercial Protein A Membranes for the Rapid Purification of Antibodies.用于快速纯化抗体的商业蛋白A膜的比较评估
Membranes (Basel). 2023 May 12;13(5):511. doi: 10.3390/membranes13050511.
2
Surrogate-based Optimization of Capture Chromatography Platforms for the Improvement of Computational Efficiency.基于替代模型的捕获色谱平台优化以提高计算效率
Comput Chem Eng. 2023 May;173. doi: 10.1016/j.compchemeng.2023.108225. Epub 2023 Mar 16.
3
Computational framework for the techno-economic analysis of monoclonal antibody capture chromatography platforms.
单克隆抗体捕获色谱平台的技术经济分析计算框架。
J Chromatogr A. 2023 Jan 25;1689:463755. doi: 10.1016/j.chroma.2022.463755. Epub 2022 Dec 24.
4
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities.通过公共卫生非专有自愿知识产权许可扩大在低收入和中等收入国家获得生物治疗药物的机会:考虑因素、要求和机会。
Lancet Glob Health. 2023 Jan;11(1):e145-e154. doi: 10.1016/S2214-109X(22)00460-0. Epub 2022 Nov 28.
5
Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?生物制药的连续集成制造:新范例还是一纸空文?
Biotechnol Bioeng. 2023 Feb;120(2):333-351. doi: 10.1002/bit.28235. Epub 2022 Sep 28.
6
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.改善欧盟、美国和日本的肿瘤生物类似药上市情况:不良反应南方网络的最新政策回顾。
Lancet Oncol. 2020 Dec;21(12):e575-e588. doi: 10.1016/S1470-2045(20)30485-X.
7
Model-based process development and evaluation of twin-column continuous capture processes with Protein A affinity resin.基于模型的双柱连续捕获工艺的开发和评估,采用 Protein A 亲和树脂。
J Chromatogr A. 2020 Aug 16;1625:461300. doi: 10.1016/j.chroma.2020.461300. Epub 2020 Jun 2.
8
Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.从常规生物制造到强化工艺提高生产力的演变:案例研究。
MAbs. 2020 Jan 1;12(1):1770669. doi: 10.1080/19420862.2020.1770669.
9
Optimization study on periodic counter-current chromatography integrated in a monoclonal antibody downstream process.周期性逆流色谱在单克隆抗体下游工艺中的优化研究。
J Chromatogr A. 2020 Jun 21;1621:461055. doi: 10.1016/j.chroma.2020.461055. Epub 2020 Mar 19.
10
Model-based process development of continuous chromatography for antibody capture: A case study with twin-column system.基于模型的连续色谱法在抗体捕获中的工艺开发:以双塔系统为例的研究。
J Chromatogr A. 2020 May 24;1619:460936. doi: 10.1016/j.chroma.2020.460936. Epub 2020 Jan 30.